Recent studies indicate that antibiotics can alter gut bacteria in ways that potentially affect blood sugar regulation, especially in those with existing metabolic conditions, though effects vary and more research is needed.
Antibiotics can sometimes do more than clear an infection. By disrupting the communities of bacteria that live in the gut, they may also nudge blood sugar control, at least for a short period, according to Indian Express and emerging research on the microbiome. Dr Adithya V. Naragund, senior consultant in GI and HPB surgery at Cytecare Hospitals in Bengaluru, said beneficial gut bacteria help regulate glucose metabolism, insulin sensitivity, inflammation and the way the body extracts energy from food.
That connection matters because the gut microbiome appears to play a supporting role in how the body handles glucose. When antibiotics reduce microbial diversity, researchers have observed temporary changes in pathways linked to insulin and inflammation, although the size of the effect varies widely from person to person. A study of healthy adults found that a short course of broad-spectrum antibiotics significantly changed gut bacteria but did not cause clinically meaningful shifts in glucose tolerance, insulin secretion or blood lipids. In other words, microbiome disruption does not necessarily translate into obvious metabolic harm in people without underlying disease.
The picture is less straightforward in other research models. Studies in mice have found that antibiotics can lower fasting glucose and improve glucose tolerance, suggesting that changes in gut bacteria can alter metabolic regulation. Reviews in the field have also linked antibiotic-driven microbiome changes with shifts in body weight, bile acid metabolism and the production of short-chain fatty acids, compounds that help maintain the intestinal barrier and may support insulin function. Those findings have prompted calls for more work on whether the same mechanisms operate in humans over the longer term.
People most likely to notice any fluctuation are those already managing diabetes, prediabetes, insulin resistance or other metabolic problems, Naragund said. In such cases, even modest changes in inflammation or insulin sensitivity may be more visible in day-to-day glucose readings. But infection itself can also push blood sugar higher through stress-hormone responses, which makes it difficult to separate the effect of illness from the effect of treatment. Naragund said the overall impact depends on the antibiotic used, how long it is taken, a person’s baseline health and diet, and how quickly the microbiome recovers afterwards.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
